Arcellx Inc (ACLX)
77.58
+0.79
(+1.03%)
USD |
NASDAQ |
Dec 24, 16:00
Arcellx Profit Margin (Quarterly): -99.37% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences Inc | 16.61% |
| Boston Scientific Corp | 11.12% |
| Johnson & Johnson | 11.99% |
| AbbVie Inc | 10.80% |
| Agios Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -9.11% |
| Return on Assets | -5.44% |
| Return on Invested Capital | -9.11% |
| Operating Margin (Quarterly) | -129.1% |
| Return on Net Operating Assets | -49.35% |